IFP Advisors
BBNX icon

IFP Advisors’s Beta Bionics BBNX Stock Holding History

IFP Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$418 Hold
22
– – ﹤0.01% 4723
2026
Q2 		$345 Buy
22
+2
+10% +$24 ﹤0.01% 4756
2026
Q1 		$200 Hold
20
– – ﹤0.01% 4618
2025
Q4 		$609 Hold
20
– – ﹤0.01% 4230
2025
Q3 		$397 Hold
20
– – ﹤0.01% 4243
2025
Q2 		$291 Buy
+20
New +$283 ﹤0.01% 4562

Other funds holding BBNX

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ING Group
ING Group Amsterdam, Netherlands $17.7B AUM 39.02% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $100B AUM 26.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

IFP Advisors's BBNX Position: Q3 2026 in Review

IFP Advisors held its Beta Bionics (BBNX) position steady in Q3 2026 at 22 shares worth $418. The position accounts for ﹤0.01% of the portfolio, ranked #4723.

IFP Advisors first reported a position in BBNX in Q2 2025 and has held it in 6 quarters since. The position peaked at $609 in Q4 2025. 76 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • IFP Advisors held 22 shares of Beta Bionics worth $418 as of Q3 2026.
  • IFP Advisors left its Beta Bionics share count unchanged in Q3 2026.
  • Beta Bionics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4723 holding.
  • IFP Advisors first reported a position in Beta Bionics in Q2 2025 and has held it in 6 quarters since.
  • IFP Advisors's Beta Bionics position peaked at $609 in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.